<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6629778\results\search\tropicalVirus\results.xml">
  <result pre="study three mosquito-borne flaviviruses that cause neurological disease in humans:" exact="West Nile," post="Dengue, and Zika. We also propose a roadmap for"/>
  <result pre="on mosquito-borne flavivirus neuropathogenesis, prevention, and treatment. mosquito-borne flavivirus flaviviridae" exact="Zika" post="virus (ZIKV) West Nile virus (WNV) Dengue virus (DENV)"/>
  <result pre="neuropathogenesis, prevention, and treatment. mosquito-borne flavivirus flaviviridae Zika virus (ZIKV)" exact="West Nile" post="virus (WNV) Dengue virus (DENV) neuropathogenesis in vitro in"/>
  <result pre="mosquito-borne flavivirus flaviviridae Zika virus (ZIKV) West Nile virus (WNV)" exact="Dengue" post="virus (DENV) neuropathogenesis in vitro in silico fig-count: table-count:"/>
  <result pre="that have recently emerged in the Western world, such as" exact="Dengue" post="virus (DENV), Zika virus (ZIKV), and West Nile virus"/>
  <result pre="emerged in the Western world, such as Dengue virus (DENV)," exact="Zika" post="virus (ZIKV), and West Nile virus (WNV), deserve attention"/>
  <result pre="world, such as Dengue virus (DENV), Zika virus (ZIKV), and" exact="West Nile" post="virus (WNV), deserve attention due to the unexpected high"/>
  <result pre="affected regions (Sips et al., 2012; Muñoz et al., 2017)." exact="WNV" post="was endemic in some regions in Europe, Asia and"/>
  <result pre="(Chancey et al., 2015). One in 150 individuals infected by" exact="WNV" post="experience a neurological disease characterized by encephalitis, meningoencephalitis, meningitis,"/>
  <result pre="et al., 2001; Mostashari et al., 2001). Mortality due to" exact="WNV" post="encephalitis ranges between 10 and 17% and increases with"/>
  <result pre="increases with age and immunosuppression state (Petersen et al., 2013)." exact="DENV" post="is the second most common mosquito-borne infection and is"/>
  <result pre="21% of cases in some reports (Domingues et al., 2008)." exact="ZIKV" post="is the most recent emerging MBF in the Americas."/>
  <result pre="in newborns and Guillain-Barré syndrome (GBS) in adults infected with" exact="ZIKV" post="was reported (do Rosário et al., 2016). Today, it"/>
  <result pre="(do Rosário et al., 2016). Today, it is known that" exact="ZIKV" post="causes fetal brain malformations and triggers GBS (Beckham et"/>
  <result pre="and triggers GBS (Beckham et al., 2016). WNV, DENV, and" exact="ZIKV" post="RNA have been found in the cerebrospinal fluid of"/>
  <result pre="MBF drug candidates are scarce. Several candidates of a human" exact="WNV" post="vaccine have undergone pre-clinical testing mainly in mice, horses,"/>
  <result pre="has been licensed for use in humans. Clinical trials for" exact="ZIKV" post="vaccines are still in the early stages. Only one"/>
  <result pre="or &quot;Dengvaxia,�? a recombinant, chimeric, live attenuated tetravalent vaccine for" exact="DENV" post="has been licensed. The manufacturing and licensing of antiviral"/>
  <result pre="The development of experimental models of neuropathogenesis following WNF and" exact="ZIKV" post="infection has thus been a central focus in preclinical"/>
  <result pre="of this virus (Chan et al., 2015). However, neuropathgogenesis of" exact="DENV" post="is generally less well studies and not a focus"/>
  <result pre="novel vaccines for MBFs has been demonstrated in primates for" exact="DENV" post="(Guirakhoo et al., 2004), WNV (Petersen et al., 2013),"/>
  <result pre="been demonstrated in primates for DENV (Guirakhoo et al., 2004)," exact="WNV" post="(Petersen et al., 2013), and ZIKV (Abbink et al.,"/>
  <result pre="(Guirakhoo et al., 2004), WNV (Petersen et al., 2013), and" exact="ZIKV" post="(Abbink et al., 2016), but their efficacy in humans"/>
  <result pre="demonstrated to favor resistance to disease after peripheral inoculation with" exact="DENV" post="and ZIKV (Clark et al., 2012; Zompi and Harris,"/>
  <result pre="favor resistance to disease after peripheral inoculation with DENV and" exact="ZIKV" post="(Clark et al., 2012; Zompi and Harris, 2012), so"/>
  <result pre="in vitro and in silico research on DENV, WNV, and" exact="ZIKV" post="and to define a roadmap for 21st century biomedical"/>
  <result pre="reduce the global burden of neurological disease caused by flavivirus." exact="DENV" post="continues its steady expansion and constitutes the most common"/>
  <result pre="expansion and constitutes the most common mosquito-borne viral disease worldwide." exact="WNV" post="is the most widespread flavivirus causing neurological disease in"/>
  <result pre="and exemplifies the potential transmission of flaviviruses outside tropical regions." exact="ZIKV" post="recently caused an unpredicted epidemic in the Americas is"/>
  <result pre="the mainstay intervention to prevent flavivirus infection. Though an efficient" exact="WNV" post="vaccine for humans is not available, vaccination of equine"/>
  <result pre="2003; El Garch et al., 2008). This is possible because" exact="WNV" post="primary reservoirs are birds and horses, while humans are"/>
  <result pre="and horses, while humans are dead-end hosts for the virus." exact="WNV" post="live attenuated vaccines are the most advanced and had"/>
  <result pre="al., 2007; Ledgerwood et al., 2011). The development of a" exact="DENV" post="vaccine has been a complex task to accomplish for"/>
  <result pre="there is no an adequate animal model that recapitulates human" exact="DENV" post="infection. Second, DENV has four antigenically different serotypes, each"/>
  <result pre="an adequate animal model that recapitulates human DENV infection. Second," exact="DENV" post="has four antigenically different serotypes, each with intrinsic genetic"/>
  <result pre="the humoral response fails to neutralize the other serotypes. Third," exact="DENV" post="heterotypic infections have been associated with an increased likelihood"/>
  <result pre="Metz, 2017). Due to these concerns the development of a" exact="DENV" post="tetravalent vaccine has been the focus over the 21st"/>
  <result pre="Villar et al., 2015). There are no approved vaccines against" exact="ZIKV" post="infection. Tebas et al. conducted a phase I clinical"/>
  <result pre="There are some phase I and II clinical trials on" exact="ZIKV" post="vaccine. However, the preliminary results will be available a"/>
  <result pre="CYD-TDV vaccine was demonstrated in naïve and seropositive patients to" exact="DENV" post="infection in India in 2016 (Dubey et al., 2016)."/>
  <result pre="a live attenuated tetravalent vaccine, in regions with 70% of" exact="DENV" post="seroprevalence. To date Dengvaxia is licensed in 11 countries"/>
  <result pre="in individuals who completed 2 or 3 doses of vaccination." exact="DENV" post="vaccine development has been limited by the lack of"/>
  <result pre="the infection and the risks attributed to past exposure to" exact="DENV" post="infections, other flaviviruses or similar vaccines. Drugs Human clinical"/>
  <result pre="prevent flavivirus infection. There are no current treatments available for" exact="DENV" post="infection. In 2016, a clinical trial testing celgosivir, an"/>
  <result pre="cultures, microphysiological system, microphysiological systems OR AND OR Zika, ZIKV," exact="West Nile," post="WNV, Dengue, DENV QSAR, molecular mechanism, molecular mechanisms, systems"/>
  <result pre="systems OR AND OR Zika, ZIKV, West Nile, WNV, Dengue," exact="DENV" post="QSAR, molecular mechanism, molecular mechanisms, systems biology, pathway, pathways,"/>
  <result pre="a high-content screening platform to study possible antiviral candidates for" exact="ZIKV" post="was developed, in which human neural progenitor cells (NPCs)"/>
  <result pre="in which human neural progenitor cells (NPCs) were treated, following" exact="ZIKV" post="infection, with over 1,000 US FDA approved drugs and"/>
  <result pre="of reviewed in vitro studies focused on DENV, followed by" exact="WNV" post="(111/412 studies) and ZIKV (73/412 studies) (Figure 1B). DENV"/>
  <result pre="studies focused on DENV, followed by WNV (111/412 studies) and" exact="ZIKV" post="(73/412 studies) (Figure 1B). DENV is considered the most"/>
  <result pre="by WNV (111/412 studies) and ZIKV (73/412 studies) (Figure 1B)." exact="DENV" post="is considered the most common mosquito-borne infection after malaria;"/>
  <result pre="common mosquito-borne infection after malaria; therefore, it was expected that" exact="DENV" post="would be the most studied MBF in the in"/>
  <result pre="There were fewer studies on ZIKV, which is understandable, because" exact="ZIKV" post="outbreaks have only raised concern in recent years. Several"/>
  <result pre="have been used to study the activation of pDC after" exact="DENV" post="infection and their potential antiviral role (Gandini et al.,"/>
  <result pre="the studies that used iPSC cells were developed to study" exact="ZIKV" post="in 3D in vitro models of the brain, such"/>
  <result pre="Such models have emerged in response to new epidemics of" exact="ZIKV" post="in the Americas and around the world as well"/>
  <result pre="studies utilized monolayer cultures (400/412 studies) and were performed on" exact="WNV" post="and DENV, while only a few papers used 3D"/>
  <result pre="3D cultures (24/412 studies), and these were mostly focused on" exact="ZIKV" post="(Cugola et al., 2016; Dang et al., 2016; Wells"/>
  <result pre="Models of Brain Pathology in MBF Infection ZIKV, DENV, and" exact="WNV" post="infection can lead to severe neurological problems. These include"/>
  <result pre="human brain was used to understand the replicative properties of" exact="WNV" post="in each cell population. It was determined that WNV"/>
  <result pre="of WNV in each cell population. It was determined that" exact="WNV" post="mainly replicates in neurons and astrocytes and that following"/>
  <result pre="Arlotta, 2017; Sloan et al., 2017). The recent outbreak of" exact="ZIKV" post="has also generated an increase in the number of"/>
  <result pre="publications focused on brain models as a platform to study" exact="ZIKV" post="(Cugola et al., 2016; Dang et al., 2016; Nowakowski"/>
  <result pre="Hartung, 2017; Booij et al., 2019) including their use for" exact="ZIKV" post="research (da Silva et al., 2018; Majolo et al.,"/>
  <result pre="more susceptible to altered cell cycle and cell death following" exact="ZIKV" post="infection (Cugola et al., 2016; Dang et al., 2016;"/>
  <result pre="Moreover, studies in cerebral organoids have shown that exposure to" exact="ZIKV" post="at early stages of differentiation disrupts organoid expansion and"/>
  <result pre="et al., 2017). Other cerebral organoid studies have shown that" exact="ZIKV" post="targets and replicates in proliferating ventricular zone (VZ) apical"/>
  <result pre="et al., 2016) and to explore the oncolytic potential of" exact="ZIKV" post="(Zhu et al., 2017). Other iPSC-derived 3D models have"/>
  <result pre="WNV, six studies on DENV, and only one study on" exact="ZIKV" post="were retrieved in this literature review). Although the current"/>
  <result pre="BBB models have been used to study membrane integrity following" exact="DENV" post="infection of endothelial cells, and these studies demonstrated an"/>
  <result pre="and these studies demonstrated an increase in vascular permeability after" exact="DENV" post="infection (Dewi et al., 2004; Talavera et al., 2004)."/>
  <result pre="(Dewi et al., 2004; Talavera et al., 2004). In addition," exact="DENV" post="has been demonstrated to induce IL-6 and IL-8 production"/>
  <result pre="al., 1998). Endothelial cells have also been used to study" exact="WNV" post="(Verma et al., 2009; Roe et al., 2014). The"/>
  <result pre="al., 2014). The majority of papers retrieved involving BBB and" exact="WNV" post="employed simplistic, monolayer cultures of human brain microvascular endothelial"/>
  <result pre="al., 2014; Roe et al., 2014; Lazear et al., 2015)." exact="ZIKV" post="presented a limited bibliography, with only one paper for"/>
  <result pre="et al., 2017). Infection studies using this model demonstrated that" exact="ZIKV" post="did not easily infect the HBMEC model, but that"/>
  <result pre="exposure to TNF-α could enhance infection (Bramley et al., 2017)." exact="ZIKV" post="has also been studied using models of other biological"/>
  <result pre="mainly used to study DENV, with fewer studies found for" exact="WNV" post="or ZIKV. Most in vitro studies on MBF infection"/>
  <result pre="role in connecting the vertebrate neuronal and immune systems in" exact="WNV" post="pathogenesis (Sultana et al., 2012). The majority of papers"/>
  <result pre="3D iPSC derived model in order to study inflammation after" exact="ZIKV" post="infection (Abreu et al., 2018). However, integrating the wider,"/>
  <result pre="1B). The majority of in silico studies were focused on" exact="DENV" post="(180/253 studies), followed by WNV (75/253 studies), and ZIKV"/>
  <result pre="silico studies were focused on DENV (180/253 studies), followed by" exact="WNV" post="(75/253 studies), and ZIKV (66/253 studies) (Figure 1B). There"/>
  <result pre="on DENV (180/253 studies), followed by WNV (75/253 studies), and" exact="ZIKV" post="(66/253 studies) (Figure 1B). There were also studies labeled"/>
  <result pre="al., 2016) or the RNA dependent RNA polymerase domain of" exact="DENV" post="(Anusuya et al., 2016; Elfiky, 2016; Manvar et al.,"/>
  <result pre="screened for their binding affinity to the structures of the" exact="ZIKV" post="protease, helicase, methyltransferase, and polymerase (Byler et al., 2016)."/>
  <result pre="their ability to bind to the viral envelope proteins of" exact="DENV" post="(Li et al., 2008; Zhou et al., 2008; Wang"/>
  <result pre="Computational approaches have been used to build on naturally occurring" exact="DENV" post="sequences, predicting novel peptide structures that display increased target"/>
  <result pre="et al., 2010). More recently, a homology model of the" exact="ZIKV" post="envelope protein was resolved, and a simulation-based approach was"/>
  <result pre="was used to demonstrate that a monoclonal antibody that neutralizes" exact="DENV" post="and WNV in vitro and in in vivo mouse"/>
  <result pre="to demonstrate that a monoclonal antibody that neutralizes DENV and" exact="WNV" post="in vitro and in in vivo mouse studies binds"/>
  <result pre="evidence that an antiviral compound binds to and inhibits the" exact="DENV" post="capsid protein (Scaturro et al., 2014). Structure-activity relationships have"/>
  <result pre="been used to identify the inhibitory functional groups of a" exact="DENV" post="NS2B-NS3 protease inhibitor identified with cell culture experiments (Tomlinson"/>
  <result pre="the stereo-electronic properties that allowed these compounds to also confer" exact="DENV" post="antiviral activity in cell culture (Balasubramanian et al., 2017)."/>
  <result pre="For example, molecular modeling of the protease-inhibitor complex of potential" exact="ZIKV" post="antivirals was used to identify structural scaffolds for allosteric"/>
  <result pre="to identify structural scaffolds for allosteric small-molecule inhibitors of the" exact="ZIKV" post="NS2B-NS3 protease, and the most potent inhibitors were then"/>
  <result pre="in vivo in mice and found to demonstrate inhibition of" exact="ZIKV" post="propagation (Shiryaev et al., 2017). Overall, the recent computational"/>
  <result pre="first step in the design of epitope-based peptide vaccines for" exact="DENV" post="(Lund et al., 2011; Jones et al., 2017), WNV"/>
  <result pre="for DENV (Lund et al., 2011; Jones et al., 2017)," exact="WNV" post="(Larsen et al., 2010), and ZIKV (Alam et al.,"/>
  <result pre="Jones et al., 2017), WNV (Larsen et al., 2010), and" exact="ZIKV" post="(Alam et al., 2016; Dikhit et al., 2016; Ali"/>
  <result pre="a tetravalent protein subunit vaccine for all four serotypes of" exact="DENV" post="(Fahimi et al., 2016). A mathematical model that simulates"/>
  <result pre="the role of both viral and human microRNA in congenital" exact="ZIKV" post="microcephaly (Pylro et al., 2016). In addition to studies"/>
  <result pre="have also been used to explore the mechanism by which" exact="DENV" post="infects and replicates within host cells (Anglero-Rodriguez et al.,"/>
  <result pre="et al., 2014), and to predict human protein interactions with" exact="DENV" post="(Doolittle and Gomez, 2011). Computational methods have also been"/>
  <result pre="also been used to identify patterns in inter-individual variation in" exact="DENV" post="viral load following infection (Ben-Shachar et al., 2016). Also,"/>
  <result pre="plasticity. Computer-based prediction of the intrinsically disordered proteins (IDP) in" exact="DENV" post="revealed a positive correlation between the level of IDP"/>
  <result pre="revealed a positive correlation between the level of IDP in" exact="DENV" post="and WNV capsid and membrane proteins and virulence (Goh"/>
  <result pre="positive correlation between the level of IDP in DENV and" exact="WNV" post="capsid and membrane proteins and virulence (Goh et al.,"/>
  <result pre="and vector life cycle model inputs to predict transmission of" exact="WNV" post="(Bouden et al., 2008; Laperriere et al., 2011; Manore"/>
  <result pre="2008; Laperriere et al., 2011; Manore et al., 2014) and" exact="DENV" post="(Fan et al., 2010; Chowell et al., 2011; Otero"/>
  <result pre="search trends or other web-based data sources for epidemics of" exact="DENV" post="(Yang et al., 2017) and ZIKV (Majumder et al.,"/>
  <result pre="sources for epidemics of DENV (Yang et al., 2017) and" exact="ZIKV" post="(Majumder et al., 2016; Wang et al., 2016; McGough"/>
  <result pre="infection is considered a major public health concern, and DENV," exact="ZIKV" post="and WNV, in particular, present a high burden of"/>
  <result pre="diagnose MBF infection and elucidate MBF reservoirs (e.g., urine in" exact="ZIKV" post="infection). Table 2 Problems and possible solutions for MBF"/>
  <result pre="T.BoydM.et al.. (2016). Protective efficacy of multiple vaccine platforms against" exact="Zika" post="virus challenge in rhesus monkeys. Science353, 1129–1132. 10.1126/science.aah615727492477 AbreuC."/>
  <result pre="vaccine: in silico approach for the epitope-based peptide vaccine against" exact="Zika" post="virus envelope glycoprotein. Immunology149, 386–399. 10.1111/imm.1265627485738 AlepeeN.BahinskiA.DaneshianM.De WeverB.FritscheE.GoldbergA.et al.."/>
  <result pre="Biol.76, 697–717. 10.1007/s11538-014-9939-524619807 AmannaI. J.SlifkaM. K. (2014). Current trends in" exact="West Nile" post="virus vaccine development. Expert Rev. Vaccines13, 589–608. 10.1586/14760584.2014.90630924689659 AmorimJ."/>
  <result pre="dengue virus infection. Virology263, 70–77. 10.1006/viro.1999.988710544083 Anglero-RodriguezY. I.PantojaP.SariolC. A. (2014)." exact="Dengue" post="virus subverts the interferon induction pathway via NS2B/3 protease-IkappaB"/>
  <result pre="B.WangG.OmaluB. I.TeshR. B.GyureK. A.ChuteD. J.et al.. (2007). Systemic distribution of" exact="West Nile" post="virus infection: postmortem immunohistochemical study of six cases. Brain"/>
  <result pre="system. Proc. Natl. Acad. Sci. U.S.A.104, 9540–9545. 10.1073/pnas.061068510417519336 AvirutnanP.MalasitP.SeligerB.BhakdiS.HusmannM. (1998)." exact="Dengue" post="virus infection of human endothelial cells leads to chemokine"/>
  <result pre="activities of selected antimalarials against dengue virus type 2 and" exact="Zika" post="virus. Antiviral Res.137, 141–150. 10.1016/j.antiviral.2016.11.01527889529 BangS.LeeS. R.KoJ.SonK.TahkD.AhnJ.et al.. (2017)."/>
  <result pre="Am. J. Trop. Med. Hyg.93, 441–453. 10.4269/ajtmh.14-062526175027 BearcroftW. G. (1956)." exact="Zika" post="virus infection experimentally induced in a human volunteer. Trans."/>
  <result pre="clinical trial. Vaccine.29, 960–968. 10.1016/j.vaccine.2010.11.05021111785 BeckhamJ. D.PastulaD. M.MasseyA.TylerK. L. (2016)." exact="Zika" post="virus as an emerging global pathogen: neurological complications of"/>
  <result pre="multicenter study to investigate the immunogenicity and safety of a" exact="West Nile" post="virus vaccine in healthy adults. J. Infect. Dis.203, 75–84."/>
  <result pre="SLAS Discov. 24, 615–627. 10.1177/247255521983008730817892 BoudenM.MoulinB.GosselinP. (2008). The geosimulation of" exact="West Nile" post="virus propagation: a multi-agent and climate sensitive tool for"/>
  <result pre="(2014). Emergency department management of mosquito-borne illness: malaria, dengue, and" exact="West Nile" post="virus. Emerg Med Pract16, 23–24. 25207355 CarteauxG.MaquartM.BedetA.ContouD.BrugièresP.FouratiS.et al.. (2016)."/>
  <result pre="Nile virus. Emerg Med Pract16, 23–24. 25207355 CarteauxG.MaquartM.BedetA.ContouD.BrugièresP.FouratiS.et al.. (2016)." exact="Zika" post="virus associated with meningoencephalitis. N. Engl. J. Med.374, 1595–1596."/>
  <result pre="5–14. 10.1016/j.antiviral.2015.08.01326304704 ChanceyC.GrinevA.VolkovaE.RiosM. (2015). The global ecology and epidemiology of" exact="West Nile" post="virus. Biomed Res. Int.2015:376230. 10.1155/2015/37623025866777 ChanprasopchaiP.PongsumpunP.TangI. M. (2017). Effect"/>
  <result pre="K.LokensgardJ. R. (2005). Differential responses of human brain cells to" exact="West Nile" post="virus infection. J. Neurovirol.11, 512–524. 10.1080/1355028050038498216338745 ChoH.SeoJ. H.WongK. H.TerasakiY.ParkJ.BongK.et"/>
  <result pre="Dis.11:164. 10.1186/1471-2334-11-16421651779 ChowersM. Y.LangR.NassarF.Ben-DavidD.GiladiM.RubinshteinE.et al.. (2001). Clinical characteristics of the" exact="West Nile" post="fever outbreak, Israel, 2000. Emerging Infect. Dis.7, 675–678. 10.3201/eid0704.01741411585531"/>
  <result pre="1519–1536. 10.1016/j.clinthera.2017.07.00128754189 CorreaA. R.BerbelA. C.PapaM. P.MoraisA. T.PeçanhaL. M.ArrudaL. B. (2015)." exact="Dengue" post="virus directly stimulates polyclonal B cell activation. PLoS ONE10:e0143391."/>
  <result pre="R.FernandesI. R.RussoF. B.FreitasB. C.DiasJ. L.GuimarãesK. P.et al.. (2016). The Brazilian" exact="Zika" post="virus strain causes birth defects in experimental models. Nature534,"/>
  <result pre="virus treatment. Viruses10:255. 10.3390/v1005025529758005 DangJ.TiwariS. K.LichinchiG.QinY.PatilV. S.EroshkinA. M.et al.. (2016)." exact="Zika" post="virus depletes neural progenitors in human cerebral organoids through"/>
  <result pre="Computational prediction and analysis of potential antigenic CTL epitopes in" exact="Zika" post="virus: a first step towards vaccine development. Infect. Genet."/>
  <result pre="187–197. 10.1016/j.meegid.2016.08.03727590716 DinizJ. A.Da RosaA. P.GuzmanH.XuF.XiaoS. Y.PopovV. L.et al.. (2006)." exact="West Nile" post="virus infection of primary mouse neuronal and neuroglial cells:"/>
  <result pre="36–40. 10.1016/j.jns.2007.09.04017959198 DoolittleJ. M.GomezS. M. (2011). Mapping protein interactions between" exact="Dengue" post="virus and its human and insect hosts. PLoS Negl."/>
  <result pre="cell localization and fate within the central nervous system during" exact="West Nile" post="Virus encephalitis. J. Immunol.193, 4095–4106. 10.4049/jimmunol.140119225200953 DwivediV. D.TripathiI. P.MishraS."/>
  <result pre="Trop. Dis.10:e0005023. 10.1371/journal.pntd.000502327764115 El GarchH.MinkeJ. M.RehderJ.RichardS.Edlund ToulemondeC.DinicS.et al.. (2008). A" exact="West Nile" post="virus (WNV) recombinant canarypox virus vaccine elicits WNV- specific"/>
  <result pre="the horse. Vet. Immunol. Immunopathol.123, 230–239. 10.1016/j.vetimm.2008.02.00218372050 ElfikyA. A. (2016)." exact="Zika" post="viral polymerase inhibition using anti-HCV drugs both in market"/>
  <result pre="impact of maturation delay of mosquitoes on the transmission of" exact="West Nile" post="virus. Math. Biosci.228, 119–126. 10.1016/j.mbs.2010.08.01020828577 FangY.EglenR. M. (2017). Three-dimensional"/>
  <result pre="Cell Stem Cell20, 397–406.e395. 10.1016/j.stem.2016.12.00528132835 GandiniM.GrasC.AzeredoE. L.PintoL. M.SmithN.DespresP.et al.. (2013)." exact="Dengue" post="virus activates membrane TRAIL relocalization and IFN-alpha production by"/>
  <result pre="10.1371/journal.pntd.000225723755314 GarcezP. P.NascimentoJ. M.de VasconcelosJ. M.Madeiro da CostaR.DelvecchioR.TrindadeP.et al.. (2017)." exact="Zika" post="virus disrupts molecular fingerprinting of human neurospheres. Sci. Rep.7:40780."/>
  <result pre="evasion. Mol. Biosyst.12, 1881–1891. 10.1039/C6MB00228E27102744 GoodfellowF. T.TeslaB.SimchickG.ZhaoQ.HodgeT.BrindleyM. A.et al.. (2016)." exact="Zika" post="virus induced mortality and microcephaly in chicken embryos. Stem"/>
  <result pre="infection. BMC Genomics11:380. 10.1186/1471-2164-11-38020553610 HasebeR.SuzukiT.MakinoY.IgarashiM.YamanouchiS.MaedaA.et al.. (2010). Transcellular transport of" exact="West Nile" post="virus-like particles across human endothelial cells depends on residues"/>
  <result pre="Biosci. Eng.6, 301–319. 10.3934/mbe.2009.6.30119364154 HuangC.SlaterB.RuddR.ParchuriN.HullR.DupuisM.et al.. (2002). First Isolation of" exact="West Nile" post="virus from a patient with encephalitis in the United"/>
  <result pre="dengue human monoclonal antibody prevents severe pathologies and death from" exact="Zika" post="virus infections. JCI Insight2:8. 10.1172/jci.insight.9242828422757 KimuraT.SasakiM.OkumuraM.KimE.SawaH. (2010). Flavivirus encephalitis:"/>
  <result pre="Simulation of the seasonal cycles of bird, equine and human" exact="West Nile" post="virus cases. Prev. Vet. Med.98, 99–110. 10.1016/j.prevetmed.2010.10.01321093946 LarsenM. V.LelicA.ParsonsR.NielsenM.HoofI.LamberthK.et"/>
  <result pre="al.. (2010). Identification of CD8+ T cell epitopes in the" exact="West Nile" post="virus polyprotein by reverse-immunology using NetCTL. PLoS ONE5:e12697. 10.1371/journal.pone.001269720856867"/>
  <result pre="M.DanielsB. P.PintoA. K.HuangA. C.VickS. C.DoyleS. E.et al.. (2015). Interferon-lambda restricts" exact="West Nile" post="virus neuroinvasion by tightening the blood-brain barrier. Sci. Transl."/>
  <result pre="Med.7:284ra259. 10.1126/scitranslmed.aaa430425904743 LedgerwoodJ. E.PiersonT. C.HubkaS. A.DesaiN.RuckerS.GordonI. J.et al.. (2011). A" exact="West Nile" post="virus DNA vaccine utilizing a modified promoter induces neutralizing"/>
  <result pre="J. Med. Chem.51, 4660–4671. 10.1021/jm800412d18610998 LiangQ.LuoZ.ZengJ.ChenW.FooS. S.LeeS. A.et al.. (2016)." exact="Zika" post="Virus NS4A and NS4B proteins deregulate Akt-mTOR signaling in"/>
  <result pre="A relevant in vitro human model for the study of" exact="Zika" post="virus antibody-dependent enhancement. J. Gen. Virol.98, 1702–1712. 10.1099/jgv.0.00083328691657 LucasM.MashimoT.FrenkielM."/>
  <result pre="LucasM.MashimoT.FrenkielM. P.Simon-ChazottesD.MontagutelliX.CeccaldiP. E.et al.. (2003). Infection of mouse neurones by" exact="West Nile" post="virus is modulated by the interferon-inducible 2′-5′ oligoadenylate synthetase"/>
  <result pre="organoids in modeling the congenital infection and neuropathogenesis induced by" exact="Zika" post="virus. J. Med. Virol.91, 525–532. 10.1002/jmv.2534530357854 MajumderM. S.SantillanaM.MekaruS. R.McGinnisD."/>
  <result pre="375–390. 10.1016/j.cell.2015.06.03426186191 MartinJ. E.PiersonT. C.HubkaS.RuckerS.GordonI. J.EnamaM. E.et al.. (2007). A" exact="West Nile" post="virus DNA vaccine induces neutralizing antibody in healthy adults"/>
  <result pre="Trop. Med. Hyg.93, 454–460. 10.4269/ajtmh.14-081926149862 MaximovaO. A.BernbaumJ. G.PletnevA. G. (2016)." exact="West Nile" post="virus spreads transsynaptically within the pathways of motor control:"/>
  <result pre="Negl. Trop. Dis.10:e0004980. 10.1371/journal.pntd.000498027617450 McGoughS. F.BrownsteinJ. S.HawkinsJ. B.SantillanaM. (2017). Forecasting" exact="Zika" post="incidence in the 2016 Latin America outbreak combining traditional"/>
  <result pre="MoserL. A.LimP. Y.StyerL. M.KramerL. D.BernardK. A. (2016). Parameters of mosquito-enhanced" exact="West Nile" post="virus infection. J. Virol.90, 292–299. 10.1128/JVI.02280-1526468544 MostashariF.BunningM. L.KitsutaniP. T.SingerD."/>
  <result pre="292–299. 10.1128/JVI.02280-1526468544 MostashariF.BunningM. L.KitsutaniP. T.SingerD. A.NashD.CooperM. J.et al.. (2001). Epidemic" exact="West Nile" post="encephalitis, New York, 1999: results of a household-based seroepidemiological"/>
  <result pre="Immunol.61, 305–317. 10.1111/1348-0421.1249728603864 NgT.HathawayD.JenningsN.ChampD.ChiangY. W.ChuH. J. (2003). Equine vaccine for" exact="West Nile" post="virus. Dev. Biol.114, 221–227. 14677692 NowakowskiT. J.PollenA. A.Di LulloE.Sandoval-EspinosaC.BershteynM.KriegsteinA."/>
  <result pre="Cell Stem Cell18, 591–596. 10.1016/j.stem.2016.03.01227038591 OhY.ZhangF.WangY.LeeE. M.ChoiI. Y.LimH.et al.. (2017)." exact="Zika" post="virus directly infects peripheral neurons and induces cell death."/>
  <result pre="of culex pipiens complex populations and assessing abatement strategies for" exact="West Nile" post="Virus. PLoS ONE9:e108452. 10.1371/journal.pone.010845225268229 PetersenL. R.BraultA. C.NasciR. S. (2013)."/>
  <result pre="Nile Virus. PLoS ONE9:e108452. 10.1371/journal.pone.010845225268229 PetersenL. R.BraultA. C.NasciR. S. (2013)." exact="West Nile" post="virus: review of the literature. JAMA310, 308–315. 10.1001/jama.2013.804223860989 PhamM."/>
  <result pre="in dendritic cells from older donors infected in vitro with" exact="West Nile" post="virus. J. Infect. Dis.203, 1415–1424. 10.1093/infdis/jir04821398396 QianX.NguyenH. N.SongM. M.HadionoC.OgdenS."/>
  <result pre="M.HadionoC.OgdenS. C.HammackC.et al.. (2016). Brain-region-specific organoids using mini-bioreactors for modeling" exact="ZIKV" post="exposure. Cell165, 1238–1254. 10.1016/j.cell.2016.04.03227118425 QuadratoG.ArlottaP. (2017). Present and future"/>
  <result pre="organoids. Curr. Opin. Cell Biol.49, 47–52. 10.1016/j.ceb.2017.11.01029227864 RaekiansyahM.Espada-MuraoL. A.OkamotoK.KuboT.MoritaK. (2014)." exact="Dengue" post="virus neither directly mediates hyperpermeability nor enhances tumor necrosis"/>
  <result pre="J.SetohY. X.EdmondsJ. H.KhromykhA. A. (2015). Comparison of attenuated and virulent" exact="West Nile" post="virus strains in human monocyte-derived dendritic cells as a"/>
  <result pre="Oswaldo Cruz102, 983–990. 10.1590/S0074-0276200700080001418209938 RetallackH.Di LulloE.AriasC.KnoppK. A.LaurieM. T.Sandoval-EspinosaC.et al.. (2016)." exact="Zika" post="virus cell tropism in the developing human brain and"/>
  <result pre="azithromycin. Proc. Natl. Acad. Sci. U.S.A.113, 14408–14413. 10.1073/pnas.161802911327911847 RoeK.OrilloB.VermaS. (2014)." exact="West Nile" post="virus-induced cell adhesion molecules on human brain microvascular endothelial"/>
  <result pre="V.MirandaM.et al. (2017). The clinically approved antiviral drug sofosbuvir inhibits" exact="Zika" post="virus replication. Sci. Rep.7:4092010.1038/srep4092028098253 SahuR.VermaR.JainA.GargR. K.SinghM. K.MalhotraH. S.et al.."/>
  <result pre="cell-derived dorsomedial telencephalic tissue. Nat. Commun.6:9896. 10.1038/ncomms989626573335 SambriV.CapobianchiM.CharrelR.FyodorovaM.GaibaniP.GouldE.et al.. (2013)." exact="West Nile" post="virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention."/>
  <result pre="Virol.88, 11540–11555. 10.1128/JVI.01745-1425056895 ShaoQ.HerrlingerS.ZhuY. N.YangM.GoodfellowF.SticeS. L.et al.. (2017). The African" exact="Zika" post="virus MR-766 is more virulent and causes more severe"/>
  <result pre="10.1242/dev.15675228993398 ShiryaevS. A.FarhyC.PintoA.HuangC. T.SimonettiN.Elong NgonoA.et al.. (2017). Characterization of the" exact="Zika" post="virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric"/>
  <result pre="10.1016/j.antiviral.2017.04.01528461069 ShresthaB.GottliebD.DiamondM. S. (2003). Infection and injury of neurons by" exact="West Nile" post="encephalitis virus. J. Virol.77, 13203–13213. 10.1128/JVI.77.24.13203-13213.200314645577 SiemannD. N.StrangeD. P.MaharajP."/>
  <result pre="J. Virol.77, 13203–13213. 10.1128/JVI.77.24.13203-13213.200314645577 SiemannD. N.StrangeD. P.MaharajP. N.ShiP. Y.VermaS. (2017)." exact="Zika" post="virus infects human Sertoli cells and modulates the integrity"/>
  <result pre="L.AlbrightR. G.KramerL. D.BernardK. A. (2011). Mosquito saliva causes enhancement of" exact="West Nile" post="virus infection in mice. J. Virol.85, 1517–1527. 10.1128/JVI.01112-1021147918 SuH."/>
  <result pre="G.MontgomeryR. R.AndersonJ. F.KoskiR. A.et al.. (2012). Semaphorin 7A contributes to" exact="West Nile" post="virus pathogenesis through TGF-beta1/Smad6 signaling. J. Immunol.189, 3150–3158. 10.4049/jimmunol.120114022896629"/>
  <result pre="Hum. Vacc. Immunother.13, 1059–1072. 10.1080/21645515.2016.126177028281864 TsaiT. F.PopoviciF.CernescuC.CampbellG. L.NedelcuN. I. (1998)." exact="West Nile" post="encephalitis epidemic in southeastern Romania. Lancet352, 767–771. 10.1016/S0140-6736(98)03538-79737281 TsaiY."/>
  <result pre="flaviviruses. QJM105, 219–223. 10.1093/qjmed/hcs01322367423 van den PolA. N.MaoG.YangY.OrnaghiS.DavisJ. N. (2017)." exact="Zika" post="virus targeting in the developing brain. J. Neurosci.37, 2161–2175."/>
  <result pre="WHO/NIH meeting report on approaches to development and licensure of" exact="Zika" post="vaccine candidates. Vaccine37, 863–868. 10.1016/j.vaccine.2018.12.04030639461 VermaS.KumarM.GurjavU.LumS.NerurkarV. R. (2010). Reversal"/>
  <result pre="vaccine candidates. Vaccine37, 863–868. 10.1016/j.vaccine.2018.12.04030639461 VermaS.KumarM.GurjavU.LumS.NerurkarV. R. (2010). Reversal of" exact="West Nile" post="virus-induced blood-brain barrier disruption and tight junction proteins degradation"/>
  <result pre="by matrix metalloproteinases inhibitor. Virology397, 130–138. 10.1016/j.virol.2009.10.03619922973 VermaS.LoY.ChapagainM.LumS.KumarM.GurjavU.et al.. (2009)." exact="West Nile" post="virus infection modulates human brain microvascular endothelial cells tight"/>
  <result pre="1896–1901. 10.1073/pnas.25278449912578971 WichapongK.NueangaudomA.PianwanitS.SipplW.KokpolS. (2013). Identification of potential hit compounds for" exact="Dengue" post="virus NS2B/NS3 protease inhibitors by combining virtual screening and"/>
  <result pre="XuM.LeeE. M.WenZ.ChengY.HuangW. K.QianX.et al.. (2016). Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
  <result pre="765–775. 10.1021/cb800176t19053243 ZhuZ.GormanM. J.McKenzieL. D.ChaiJ. N.HubertC. G.PragerB. C.et al. (2017)." exact="Zika" post="virus has oncolytic activity against glioblastoma stem cells. J."/>
 </snippets>
</snippetsTree>
